Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Vifor Pharma
Vifor Pharma
Activities:
Manufacturing
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
Vifor Pharma to propose Åsa Riisberg for board of directors
Riisberg holds a MSc in Financial Economics and Business Administration from Stockholm School of Economics
Ingredients
Vifor Pharma enters Chinese joint venture with Fresenius Kabi
Joint venture will bring IV Iron to China to replace the wasteful blood transfusions that are the current prevailing treatment for iron deficiency anaemia
Finance
Vifor Pharma enters commercial diabetes collaboration in the US
The Swiss pharma company will work with US-based Janssen to jointly commercialise INVOKANA (canagliflozin) in the US to address complications of type 2 diabetes
Drug Delivery
PIVOTAL trial confirms long-term safety and efficacy of IV iron dosing
The long-term safety and efficacy of intravenous iron dosing has been confirmed allowing higher Ferritin concentration and transferrin saturation in patients undergoing haemodialysis
Recruitment
Vifor pharma announces management changes
Media
Vifor Pharma proposes Jacques Theurillat as board member
Pharmaceutical
Kissei to market Avacopan in Japan for Vifor Pharma
Vifor Fresenius Medical Care Renal Pharma has granted Japanese pharmaceutical company, Kissei, exclusive rights to develop and commercialise Avacopan in Japan
Subscribe now